Skip to content

Comparative Study of Metformin Versus Doxycycline in Moderate to Severe Adult Acne Vulgaris Patients.

Comparative Study of Metformin Versus Doxycycline in Treatment of Moderate to Severe Adult Acne Vulgaris Patients: Multicentre, Randomized, Double-blind Trial.

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06252194
Enrollment
120
Registered
2024-02-09
Start date
2023-03-05
Completion date
2024-03-31
Last updated
2024-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne Vulgaris

Brief summary

The goal of this clinical trial is to compare the effect of doxycycline and metformin in treatment of acne vulgaris patients. The main question is aimed to answer is whether metformin is more effective than doxycycline in treatment of acne vulgaris patient or not. Patients will be asked to take doxycycline along with tropical treatment in one group and metformin along with tropical treatment in another group. Researcher will compare the clinical improvement in two groups.

Interventions

DRUGMetformin and doxycycline

Metformin 500 mg tablet twice daily

Sponsors

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Newly diagnosed moderate and severe AV patients diagnosed by a dermatologist \-

Exclusion criteria

* Patients receiving topical retinoids within last two months * Pregnancy and lactation * History of corticosteroids intake * Suffering from malignancy or any cosmetic induced acne

Design outcomes

Primary

MeasureTime frameDescription
Global Acne Grading System (GAGS) Score12 weeksAcne Vulgaris Severity assesment by GAGS score

Countries

Bangladesh

Contacts

Primary ContactMuhammad Marnush, MBBS
marnushm@gmail.com88001714558447

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026